The Nanostim implantable pacemaker made by St. Jude Medical (NYSE:STJ) met its 6-month safety and efficacy endpoints, according to data presented over the weekend at the annual meeting of the European Society of Cardiology in London and published in the New England Journal of Medicine. The Leadless II study enrolled 526 patients in the primary cohort, with 300 […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Biotronik launches China arm in Orsiro stent trial
Biotronik said today it enrolled the 1st patient in its new Chinese Bioflow-VI study of its Orsiro drug-eluting stent for treating patients with coronary artery disease. The prospective, multi-center trial is slated to enroll 440 patients at 15 sites in China to support Chinese market approval of the Orsiro drug-eluting stent. “Based on the wealth […]
Mitralign wins FDA nod for tricuspid valve feasibility trial
Mitralign said today that the FDA approved a U.S. feasibility study of its tricuspid valve repair device, under an investigational device exemption. Tewksbury, Mass.-based Mitralign did not provide any details on the Scout study or its design for its percutaneous tricuspid valve annuloplasty device, other than that it will occur at “select” sites in the […]
Medtronic says a pair of studies show genetic link to sudden cardiac death
Medtronic (NYSE:MDT) today said 1st-of-a-kind results from a pair of independent clinical trials discovered a gene linked to abnormal heart rhythms that can lead to sudden cardiac death. Fridley, Minn.-based Medtronic said the studies, Discovery and Oregon SUDS, found a gene associated with SCD in patients with implantable cardioverter defibrillators. Results were presented over the weekend […]
Biotronik wins CE Mark for BioMonitor 2
Biotronik said yesterday it won CE Mark approval in the European Union for its BioMonitor 2 subcutaneous insertable cardiac monitor and released results of a pilot study of the device. The device is designed for remote monitoring of patients with atrial fibrillation, syncope, bradycardia and tachychardia, Biotronik said. The Australian pilot study reported an average […]
Edwards Lifesciences closes $400m CardiAQ Valve buyout
Edwards Lifesciences (NYSE:EW) said yesterday that it closed the $400 million buyout of CardiAQ Valve Technologies and its transcatheter mitral valve implant. The deal for CardiAQ Valve, which like Edwards is based in Irvine, Calif., included an up-front payment of $350 million in cash and another $50 million pegged to “achievement of a European regulatory milestone,” Edwards said. Edwards is […]
TMVI heats up: Medtronic to drop $458m on Twelve’s mitral valve
Medtronic (NYSE:MDT) said today that it agreed to pony up as much as $458 million for Twelve Inc. and its transcatheter mitral valve implant, as the race to get a TMVI device to market heats up. Twelve, a spinout from the Foundry incubator that’s based in Redwood City, Calif., is backed by Domain Associates, Versant Ventures, Morgenthaler […]
Boston Scientific adds MR-safe label to some EU defibs
Boston Scientific (NYSE:BSX) said yesterday that it added MR-conditional labeling to the CE Mark for some of the defibrillators it sells in the European Union, claiming the title for Europe’s largest portfolio of MRI-compatible devices. Marlborough, Mass.-based Boston Scientific said its EL extended longevity and Mini implantable cardiac defibrillators and the X4 cardiac resynchronization therapy defibrillators are now cleared to be […]
St. Jude floats $2.6b for Thoratec buy
St. Jude Medical (NYSE:STJ) is taking out a 5-year, $2.6 billion loan from Bank of America to fund its $3.4 billion purchase of Thoratec (NSDQ:THOR), according to an SEC filing. According to the loan terms, $2.1 billion of the funds will go entirely towards the cost of acquiring Thoratec, with $500 million slated to be used to […]
‘Go-shop’ lapses without new rival for St. Jude’s $3B Thoratec buy
A 30-day “go-shop” period in St. Jude Medical‘s (NYSE:STJ) pending, $3.4 billion acquisition of Thoratec (NSDQ:THOR) lapsed last week without a 2nd suitor emerging, sending the companies’ stock prices down slightly last Friday. The merger, medtech’s latest multi-billion union, calls for St. Jude to pay $63.50 in cash for each share of Pleasanton, Calif.-based Thoratec, funded using term loans […]
Micell gains new manufacturing partner
Micell Technologies said today that it won approval to partner with contract manufacturer Surgical Technologies, Inc. in Britain and will begin full-scale manufacturing of its MiStent SES for distribution to European Union countries. Micell won CE Mark approval in the European Union for the drug-eluting stent in 2013. STI will serve as the primary contract manufacturer of the […]